October 7, 2025 — Leads & Copy — GeneDx (Nasdaq: WGS) will release its financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025. Management will host a conference call that day at 8:30 a.m. Eastern Time to discuss the results.
Investors interested in listening to the conference call are required to register online. A live and archived webcast will be available on the “Events” section of the GeneDx investor relations website.
GeneDx (Nasdaq: WGS) is the global leader in rare disease diagnosis. The company transforms medicine by making genomics the starting point for health. GeneDx brings together clinical expertise, advanced technology, and the GeneDx Infinity™ dataset. Its ExomeDx and GenomeDx tests give clinicians a high likelihood of delivering an accurate diagnosis. GeneDx is shaping the future of healthcare by moving the standard of care from sick care to proactive healthcare.
For more information, connect with GeneDx on LinkedIn, Facebook, and Instagram.
Source: GeneDx
